ICU幸存者自信心在执行功能与抑郁关系中的中介作用:潜变量分析
该横断面研究在瑞典一所大学医院三个ICU中纳入395例成人ICU幸存者(ICU停留至少72小时),于出院后6个月至3年填写问卷,评估执行功能、自信心与抑郁。采用结构方程模型和验证性因子分析,发现抑郁症状与自信心下降(r=0.80,p<0.001)、执行功能较差(r=0.55,p<0.001)正相关,自信心下降与执行功能受损相关(r=0.62,p<0.001)。中介分析显示执行功能对抑郁的效应完全由自信心中介(B=0.45;95%CI 0.34-0.59),纳入自信心后直接效应不显著(B=0.07,p=0.18),模型拟合可接受(CFI=0.962;RMSEA=0.075)。作者认为提升自信心的干预可能减轻ICU幸存者的抑郁症状,但需纵向研究确认。
要点
- ICU幸存者中执行功能受损对抑郁症状的效应完全由自信心下降中介(B=0.45;95%CI 0.34-0.59)。
- 纳入自信心后,执行功能对抑郁的直接效应不显著(B=0.07,p=0.18)。
- 抑郁症状与自信心下降(r=0.80,p<0.001)、执行功能较差(r=0.55,p<0.001)正相关。
- 自信心下降与执行功能受损相关(r=0.62,p<0.001);男性性别与较高自信心正相关。
- 年龄与抑郁、自信心、执行功能均呈负相关;模型拟合可接受(CFI=0.962;RMSEA=0.075)。
适用人群与场景
- 瑞典一所大学医院三个ICU的成人ICU幸存者,ICU停留至少72小时,于出院后6个月至3年填写问卷。
研究设计与关键结果
- 研究类型为横断面研究,使用临时问卷评估生活质量,纳入395例成人ICU幸存者,来自一所瑞典大学医院的三个ICU,ICU停留至少72小时,出院后6个月至3年。
- 抑郁症状与自信心下降正相关(r=0.80,p<0.001),与执行功能较差正相关(r=0.55,p<0.001);自信心下降与执行功能受损相关(r=0.62,p<0.001)。
- 年龄与抑郁、自信心、执行功能均呈负相关;男性性别与较高自信心正相关。
- 中介分析显示执行功能受损对抑郁症状的效应完全由自信心下降中介(B=0.45;95%CI 0.34-0.59);纳入自信心后执行功能对抑郁的直接效应不显著(B=0.07,p=0.18)。
- 模型拟合可接受(CFI=0.962;RMSEA=0.075);信度采用McDonald's Omega和Cronbach's Alpha评估。
- 试验注册:ClinicalTrials.gov Ref# NCT02767180;注册日期2016年4月28日。
证据类型、等级与局限
- 证据类型:横断面研究(潜变量分析,结构方程模型与验证性因子分析)。
- 局限:原文报告需纵向研究确认这些发现并进一步探索因果通路。
对床旁实践的改变
- 作者认为,旨在提升自信心的干预可能减轻ICU幸存者人群的抑郁症状。
- 作者建议需纵向研究确认这些发现并进一步探索因果通路。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Executive dysfunction and depression are common among ICU survivors, yet the mechanisms linking these two factors remain poorly understood. Self-confidence has been implicated as a key mediator in the relationship between cognitive impairments and mental health outcomes. This study aimed to explore the mediating role of self-confidence in the association between executive functioning and depression in ICU survivors.
METHOD: A provisional questionnaire was used in a cross-sectional study to assess quality of life in 395 adult ICU survivors, each with a minimum 72-h stay at one of three ICUs at a Swedish university hospital, six months to three years post-discharge. Responses to questions on executive function, self-confidence, and depression were analysed. Structural equation modelling and confirmatory factor analysis were employed to examine the mediating effect of self-confidence on the relationship between executive function and depression. Model fit was evaluated using established indicators. Reliability of the measures was assessed using McDonald's Omega and Cronbach's Alpha.
RESULTS: A significant positive correlation was found between depressive symptoms and both diminished self-confidence (r = 0.80, p < 0.001) and poorer executive function (r = 0.55, p < 0.001). Additionally, a correlation was observed between reduced self-confidence and compromised executive function (r = 0.62, p < 0.001). Age was negatively associated with depression, self-confidence, and executive function, while male gender was positively correlated with higher self-confidence. Mediation analysis revealed that the effect of impaired executive function on depressive symptoms was fully mediated by diminished self-confidence (B = 0.45; 95% CI 0.34-0.59). The direct effect of executive function on depression became non-significant when self-confidence was included in the model (B = 0.07, p = 0.18), suggesting complete mediation. The overall model fit was satisfactory (CFI = 0.962; RMSEA = 0.075), highlighting the robustness of the mediation pathway.
CONCLUSIONS: Self-confidence mediates the relationship between executive function and depression among ICU survivors. Interventions aimed at enhancing self-confidence could mitigate depressive symptoms in the ICU survivor population. Longitudinal studies are needed to confirm these findings and further explore the causal pathways involved. Trial registration ClinicalTrials.gov Ref# NCT02767180; Registered 28 April 2016.
参考来源
- Johannesson E, Malmgren J. Self-confidence as a mediator in the relationship between executive functioning and depression among ICU survivors: a latent variable analysis. Crit Care. 2024. PMID: 39462425. doi:10.1186/s13054-024-05136-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。